NEW YORK, April 9 - Eisai, a Japanese health care and pharmaceutical company, has signed a multi-year subscription to Incyte Genomics' LifeSeq Gold human sequence and ZooSeq animal model databases, the company said Monday.

Researchers at Eisai, which is based in Tokyo, will have 24-hour online access to the databases and to information technology support, Incyte said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.